On 04 December, Symantec Corporation (NASDAQ:SYMC) shares moved up 1.67% and was closed at $20.04. SYMC EPS growth in last 5 year was 7.70%. Symantec Corporation (NASDAQ:SYMC) year to date (YTD) performance is -19.77%.
Symantec Corporation (NASDAQ:SYMC) Board of Directors has declared a quarterly cash dividend of $0.15 per common share to be paid on December 16, 2015 to all shareholders of record as of the close of business on November 23, 2015. The ex-dividend date will be November 19, 2015.
American Tower Corporation (NYSE:AMT) ended the last trading day at $97.55. Company weekly volatility is calculated as 1.78% and price to cash ratio as 136.86. American Tower Corporation (NYSE:AMT) showed a weekly performance of -2.14%.
American Tower Corporation (NYSE:AMT) announced that its board of directors has declared its quarterly cash distribution of $0.49 per share on shares of the Company’s common stock. The distribution is payable on January 13, 2016 to such stockholders of record at the close of business on December 16, 2015.
On 04 December, General Dynamics Corporation (NYSE:GD) shares increased 1.32% and was closed at $143.84. GD EPS growth in last 5 year was 4.70%. General Dynamics Corporation (NYSE:GD) year to date (YTD) performance is 6.57%.
On 5 December, General Dynamics Corporation (NYSE:GD) reported that, its unit General Dynamics NASSCO delivered the ‘Lone Star State’ tanker to American Petroleum Tankers, its first ECO Class tanker that is more eco-friendly and fuel-efficient compared to previous tankers.
B2Gold Corp. (NYSEMKT:BTG) shares increased 6.84% in last trading session and ended the day at $1.25. B2Gold Corp. (NYSEMKT:BTG) quarterly performance is -2.34%.
On 24 November, B2Gold Corp. (NYSEMKT:BTG) said that, it has provided the Company with initial drill results from a 12 hole, 2,124 metre drill program on the Pampa Paciencia epithermal gold SILVER PROJECT.
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) caters to the Healthcare space. Its weekly performance is -6.70%. On the last day of trading company shares ended up at $7.80. Sorrento Therapeutics, Inc. (NASDAQ:SRNE) distance from 50-day simple moving average (SMA50) is 4.63%.
Sorrento Therapeutics, Inc. (NASDAQ:SRNE) had its target price reduced by Brean Capital from $26.00 to $15.00 in a report issued on Wednesday morning, Analyst Ratings Net reports. They currently have a buy rating on the biopharmaceutical company’s stock.
Leave a Reply